Virginia Angiolini

Consejo Nacional de Investigaciones Científicas y Técnicas — Argentina

Biochemistry, Genetics and Molecular Biology · Life Sciences

3h-index75citations30works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Microtubule and mitosis dynamics(18), Biotechnology and Related Fields(10), Genetics, Bioinformatics, and Biomedical Research(8), BRCA gene mutations in cancer(3), MicroRNA in disease regulation(2)

Publications30 total

1,25 dihydroxyvitamin D3-mediated effects on bovine innate immunity and on biofilm-forming Staphylococcus spp. isolated from cattle with mastitis
The Journal of Steroid Biochemistry and Molecular Biology·2024· 1 cited
Figure S5 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S3 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Supplementary Methods from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S2 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Supplementary Methods from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S1 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S2 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S6 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S6 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Data from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S4 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S3 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S1 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S4 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S5 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Table S1 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Table S1 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Data from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
Clinical Cancer Research·2019· 35 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Sofía Carbajosa(20), María Florencia Pansa(20), Iris Alejandra García(20), Lucía Rodriguez-Berdini(20), Laura Guantay(20), Florencia Villafañez(20), Kevin P. Madauss(20), Israel Gloger(20), José Luís Bocco(20), Vanesa Gottifredi(20), Gastón Soria(20), Natalia S. Paviolo(19), Andrés M. Castellaro(19), Ayelén D. Nigra(19), Ana C. Racca(19), María Celeste Rodríguez-Baili(19), Beatriz L. Caputto(19), Gerard Drewes(19), Elmer A. Fernández(19), Germán A. Gil(19)